Big News Coming for the Patient, page-20

I find it worrysome that the wait for 1 year until acne trials are complete is considered "long". Not just from your individual perspective, but in the share market at these MC levels all round. Surely an investment to achieve production is the most rewarding aspect of participating? I get the feeling that the immediate gratitude needs of the 'Millenials' is going to create poor production outcomes with greed and fear in the short term dominating capital flows. But, with this little company, I see a lean, efficient, process in play with products that can be outstanding, if early indications prove correct, and I will enjoy the wait until BOT produce a treatment that I can consider myself a part of its creation.